Browsing by Subject "Rodent Model"
Now showing 1 - 4 of 4
Results Per Page
Sort Options
Item Developing a Rodent Model of Adverse Menopausal Symptoms(Office of the Vice Chancellor for Research, 2011-04-08) Snow, Winter; Federi, Lauren; Fitz, Stephanie; Janasik, Stephen; Penno, Daniel; Samuels, Brian; Carpenter, Janet; Skaar, Todd C.; Shekhar, Anantha; Johnson, Philip L.Menopause is a condition where severe depletion of estrogen levels leads to a cluster of adverse symptoms such as anxiety, cutaneous vasodilation/sudomotor "hot flashes", sleep disturbances, and appetite change (Freeman et al., 2005; Seritan et al., 2010). Previously, estrogen replacement therapy was the first line treatment for menopausal symptoms. However, it is no longer acceptable due to increased risk of cancer (Rossouw et al., 2002). Therefore there is a need for creating non-hormonal therapies to reduce the incidence of adverse menopausal-related symptoms. This is hindered by the limited understanding of menopausal symptoms and a lack of animal models of "hot flashes" (Nelson et al., 2006). Currently, the most accepted model of hot flashes is addicting female rats to morphine then inducing morphine withdrawal using naloxone (a ?-opioid receptor competitive antagonist) to provoke increases in tail temp (an indicator of cutaneous vasodilation). Yet, there is no evidence that the opioid system is disrupted in women with menopause [e.g., naloxone does not provoke "hot flashes" clinically (DeFazio et al., 1984)]. Here we induced a menopausal state by surgically removing the ovaries (OVEX) to deplete estrogen which induces a cluster of adverse menopause-like symptoms that include: 1) increased anxiety; 2) weight gain; and 3) disrupted diurnal skin and core body tempature changes. Additionally, we have developed an alternative model of "hot flashes" where administering yohimbine (an alpha2-adrenergic autoreceptor antagonist that provokes "hot flashes in menopausal women) resulted in "hot flash"-related increases in skin temp in OVEX, but not sham-OVEX, female rats.Item Drinking Rhythms in Alcohol Preferring Mice(2012-08-29) Matson, Liana M.; Grahame, Nicholas J.; Czachowski, Cristine; Boehm II, Stephen L.Multiple lines of High Alcohol Preferring (HAP) mice were selectively bred for their intake of 10% ethanol (v/v) during 24-h daily access over a four-week period, with the highest drinking lines exhibiting intakes in excess of 20 g/kg/day. Drinking rhythms and corresponding blood ethanol concentrations (BEC) of the highest drinking HAP lines to those of the C57BL/6J (B6) inbred strain. Adult male and female crossed HAP (cHAP), HAP1 and B6 mice had free-choice access to 10% ethanol and water for 3 weeks prior to bi-hourly assessments of intake throughout the dark portion of a reverse 12:12 light dark cycle. In another cohort of cHAP mice, the same procedure was used to assess bi-hourly ethanol intake, and blood samples were taken across the day to look at the pattern of accumulation in these mice. Finally, considering the high level of intake by cHAP mice, we were interested in assessing whether metabolic and functional tolerance develop following chronic free-choice access, which were assessed using 2.0 and 1.75 g/kg challenge doses of 20% ethanol, respectively. cHAP and HAP1 mice maintained an excessive level of intake throughout the dark portion of the cycle, accumulating mean BEC levels of 261.5 + 18.09 and 217.9 + 25.02 mg/dl at 7-8 hours following lights off, respectively. B6 mice drank comparatively modestly, and did not accumulate high BEC levels (53.63 + 8.15 mg/dl). In the cHAP cohort, mean BECs were 112.47 + 19.91 at 2 hours after lights off, 189.00 + 27.40 at 6 hours after lights off, 193.80 + 29.66 at 10 hours after lights off, and 89.68 + 22.19 at 2 hours after lights on. Further, following 3 weeks of ethanol access, cHAP mice had a faster rate of ethanol metabolism and fewer hind slips than water-only exposed mice (ps < .05). In conclusion, the excessive free-choice drinking demonstrated by the HAP1 and cHAP lines, as well as the pattern of sustained high BECs in cHAP mice, challenge the notion that rodents will not reliably and voluntarily sustain ethanol intake at pharmacologically relevant levels. These results suggest that the highest drinking HAP lines may provide a unique opportunity for modeling the excessive intake that has been observed in alcohol-dependent individuals. Further, we observed that cHAP mice develop both metabolic and functional tolerance to the ataxic effects of ethanol following 3 weeks of free-choice access. Together, these findings support HAP mice as translational rodent model of alcoholism, and provide rationale for exploration of the predisposing factors for excessive consumption, as well as the development of physiological, behavioral, and toxicological outcomes following alcohol exposure.Item Investigating reactivity to incentive downshift as a correlated response to selection for high alcohol preference and a determinant of rash action and alcohol consumption(2014) Matson, Liana M.; Grahame, Nicholas J.; Czachowski, Cristine; Boehm, Stephen; Cyders, Melissa A.; Chester, Julia A.Losing a job or a significant other are examples of incentive shifts that result in negative emotional reactions. The occurrence of negative life events is associated with increased drinking, and alleviation of negative emotions has been cited as a drinking motive for individuals with problematic drinking patterns (Keyes et al., 2011; Adams et al., 2012). Further, there is evidence that certain genotypes drink alcohol in response to stressful negative life events (Blomeyer et al., 2008; Covault et al., 2007). It is possible that shared genetic factors contribute to both alcohol drinking and emotional reactivity, but there is a critical need for this relationship to be understood. The first aim of this proposal will use an incentive downshift paradigm to address whether emotional reactivity is elevated in mice predisposed to drink alcohol. The second aim of this proposal will address if reactivity to an incentive shift can result in rash action using a differential reinforcement of low rates of responding task, and whether this response is also associated with a predisposition for high drinking. The third aim of this proposal will investigate if experimenter administered ethanol reduces contrast effects, and if an incentive shift increases ethanol consumption in a high drinking line. The overall goal of this proposal is to investigate whether reactivity to incentive shift is an important mechanism underlying alcohol drinking in these mice, and the role an incentive shift may play in producing rash action and influencing ethanol consumption.Item Validation of a Rodent Model of Chemotherapy-Induced Peripheral Neuropathy Using Oxaliplatin(Office of the Vice Chancellor for Research, 2016-04-08) Smith, J.; Ripsch, M.S.; White, F.A.Oxaliplatin (OXPL) is one of the most widely used and effective chemotherapeutic agents for colorectal cancer. However, the drug therapy is accompanied by severe dose-limiting off-target effects including tingling, burning pain and mechanical allodynia in the extremities of patients; together these symptomology is better known as chemotherapy-induced peripheral neuropathy (CIPN). The underlying pathophysiological mechanisms of CIPN are poorly understood and current therapeutic options only serve to alleviate the symptoms rather than prevent CIPN. To better understand mechanisms of OXPL-induced CIPN (OXPLN), we exposed adult female Sprague-Dawley rats to four intraperitoneal injections of vehicle or OXPL on alternative days. Behavioral results showed that thermal sensitivity failed to be affected by the OXPL. In contrast, the magnitude of mechanical allodynia increased such that the baseline withdrawal threshold for drug-treated animals was significantly lower than that for unprimed animals. Application of OXPL to afferent sensory neurons produced an increased amplitude and duration of compound action potentials that could be reversed with the voltage-gated sodium channel blocker, carbamazepine (CBZ). Astroglial and microglial markers glial fibrillary acidic protein (GFAP) and Iba-1 were imaged to examine glial reactivity in OXPLN at day 14. Microglia were not activated following OXPL whereas astrocytes exhibited increased GFAP fluorescence which paralleled OXPLN. Activation of astrocytes was prevented by co-administration of CBZ. These observations suggest that CBZ may serve to diminish OXPLN in the patient population. Oxaliplatin (OXPL) is one of the most widely used and effective chemotherapeutic agents for colorectal cancer. However, the drug therapy is accompanied by severe dose-limiting off-target effects including tingling, burning pain and mechanical allodynia in the extremities of patients; together these symptomology is better known as chemotherapy-induced peripheral neuropathy (CIPN). The underlying pathophysiological mechanisms of CIPN are poorly understood and current therapeutic options only serve to alleviate the symptoms rather than prevent CIPN. To better understand mechanisms of OXPL-induced CIPN (OXPLN), we exposed adult female Sprague-Dawley rats to four intraperitoneal injections of vehicle or OXPL on alternative days. Behavioral results showed that thermal sensitivity failed to be affected by the OXPL. In contrast, the magnitude of mechanical allodynia increased such that the baseline withdrawal threshold for drug-treated animals was significantly lower than that for unprimed animals. Application of OXPL to afferent sensory neurons produced an increased amplitude and duration of compound action potentials that could be reversed with the voltage-gated sodium channel blocker, carbamazepine (CBZ). Astroglial and microglial markers glial fibrillary acidic protein (GFAP) and Iba-1 were imaged to examine glial reactivity in OXPLN at day 14. Microglia were not activated following OXPL whereas astrocytes exhibited increased GFAP fluorescence which paralleled OXPLN. Activation of astrocytes was prevented by co-administration of CBZ. These observations suggest that CBZ may serve to diminish OXPLN in the patient population.